Investigating Breast Cancer

Latest Episodes:

Unraveling the Mysteries of Inherited Gene Mutations with Dr. Ephrat Levy-Lahad Sep 01, 2021

Show notes

How can genetic testing data encourage prevention and agency without amplifying personal fear? What can research reveal about genetic markers of risk and predisposition? Or, put differently, how can understanding one’s inherited risk improve approaches to precision prevention?

Dr. Ephrat Levy-Lahad is on the forefront of this research, focusing on breast cancer–associated genetic mutations among various populations, including Arab and Ashkenazi Jewish women. She is a professor of internal medicine and medical genetics at Hebrew University and director of the Medical Genetics Institute at Shaare Zedek Medical Center in Jerusalem.

Perfecting and Personalizing Risk Assessment with Dr. Katherine Nathanson Jul 30, 2021

Show notes

While breast cancer is not typically caused by inherited factors, as many as 10-15 percent of people diagnosed with breast cancer carry a known genetic mutation. The most well-known mutations are in the BRCA1 and BRCA2 genes. But these only account for 5-10 percent of inherited breast cancers, so what about the many other gene mutations that increase a person’s risk of breast cancer? Also, what does this mean not only for genetic testing—but also how we should consider results? More significantly, what effect might this have on the personalization of risk?

We talk with BCRF investigator and cancer geneticist Dr. Katherine Nathanson to answer these questions.

New Approaches to Reducing Repeat Breast Cancer Surgeries with Dr. Mehra Golshan Jun 10, 2021

Show notes

There are many challenges in managing breast cancer. Top among them is the fact that initial breast conserving surgeries often miss vestiges of a patient’s tumor. In fact, up to 40 percent of women require another procedure following lumpectomy. Not only can additional surgery, of course, increase a patient’s anxiety and be physically taxing, but it can cause delays in critical subsequent treatments like chemotherapy and radiation.

So, why is that rate so high? Why is properly identifying the tumor so difficult? Most importantly: What can be done to reduce repeat surgeries? Dr. Mehra Golshan is working to uncover answers to these questions.

A BCRF investigator since 2014, Dr. Golshan is the deputy chief medical officer for surgical services and director of the Breast Cancer Program for the Yale Cancer Center, Smilow Cancer Hospital, and Smilow Cancer Hospital Care Centers.

Improving the Quality of Life for Breast Cancer Patients and Survivors with Professor Dame Lesley Fallowfield May 13, 2021

Show notes

How do you measure quality of life? As researchers across fields discover new drug therapies or disease prevention—in breast cancer as well as other fields—science finds innumerable ways to measure physical results. But what about the social, behavioral, and psychological aspects of cancer care? And how should medical providers discuss such realties with patients?

This is just one area of extraordinary impact that Professor Dame Lesley Fallowfield has made in medicine. Dame Lesley is professor of psycho-oncology at Brighton & Sussex Medical School at the University of Sussex where she is director of the Sussex Health Outcomes Research & Education in Cancer group.

She has been a BCRF Investigator since 2016—the same year she was made a Dame Commander of the Order of the British Empire by Queen Elizabeth II for services to psycho-oncology.

Understanding Radiation Resistance and Barriers to Quality Care with Dr. Lori Pierce Feb 25, 2021

Show notes

For so many breast cancer patients, radiation therapy can bring extraordinary benefits—top among them improved survival rates and reduced recurrence. But there are also challenges and questions: Why do some people experience a recurrence after treatment? How can we reduce side effects? How can we ensure the right patients receive radiation therapy—and that the treatment works as well as possible?

These are among the many medical mysteries to which Dr. Lori Pierce, BCRF investigator since 2003, has dedicated her career to answering.

Connecting the Dots Between Breast Cancer Risk and Obesity, with Dr. Vared Sterns Jan 27, 2021

Show notes

Women with breast cancer who are overweight or obese experience inferior outcomes compared to those with normal weight despite receiving optimal therapies. Dr. Vered Stearns discusses researching ways to reduce breast cancer recurrence through effective weight-loss interventions and why we need to bring more discoveries from the lab to the clinic. Dr. Stearns is a member of the BCRF Scientific Advisory Board and has been a BCRF Investigator since 2003.

BCRF Symposium and Awards Luncheon 2020 Dec 10, 2020

Show notes

Each October, BCRF-funded investigators are honored at the Foundation’s Symposium & Awards Luncheon in New York City. This year, the program was held virtually, without the lunch—but with all of the important conversations and ideas.

The annual event announces the Foundation’s grant investment for the coming year and recognizes BCRF investigators for their trailblazing scientific inquiry. This year’s program included an extraordinary symposium, moderated by BCRF Scientific Director Dr. Judy Garber, that included Dr. Angela DeMichele, Dr. William G. Kaelin Jr. and Dr. Lori J. Pierce.

We’re proud to make their discussion available in a special episode of Investigating Breast Cancer.

Improving National and Global Racial Disparities in Breast Cancer Care with Dr. Funmi Olopade Nov 25, 2020

Show notes

Women of African descent are more likely to be diagnosed with aggressive breast cancers than white women and are more likely to die from their disease regardless of its type or stage. For those living in remote or low-resource areas, limited access to screening and genetic testing make improving outcomes even more challenging.

In this episode of our podcast, Dr. Funmi Olopade, talks about her work in Africa and Chicago, the critical importance of precision medicine, and why she’s “impatient” about eliminating barriers to breast cancer care around the world. Dr. Olopade, a BCRF investigator since 2001, serves as the founding director of the Cancer Risk and Prevention Clinic and associate dean for global health, both at the University of Chicago.

A Closer Look at the Evolution of Breast Cancer Cells with Dr. Kornelia Polyak Oct 28, 2020

Show notes

The immune system plays a critical role in tumor growth by attacking cancer cells with white blood cells. Cancer cells that survive this immune attack can become invasive and metastatic (a process called immune escape). In this episode of Investigating Breast Cancer, Dr. Kornelia Polyak shares the impact of understanding breast cancer at a molecular level. Dr. Polyak, a BCRF investigator since 2008, is an internationally recognized leader in the breast cancer research field.

Exploring the Many Intersections of Health Equity in Latin America with Dr. Jeffrey Weitzel Sep 28, 2020

Show notes

While genetic testing and counseling for breast cancer has been available in the U.S. for many years, accessing these services in Mexico and the rest of Latin America is more challenging due to limited resources. Leading genetics researcher and oncologist, Dr. Jeffrey Weitzel, has devoted his career to decreasing these barriers. Dr. Weitzel, a BCRF investigator since 2013, is director of the Clinical Cancer Genetics Program and professor of oncology and population sciences at the Beckman Research Institute at City of Hope.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Investigating Breast Cancer

Related Podcasts

Links

Stay Connected